{"id":8683,"date":"2020-08-03T10:45:13","date_gmt":"2020-08-03T17:45:13","guid":{"rendered":"https:\/\/depts.washington.edu\/pandemicalliance\/?p=8683"},"modified":"2021-04-06T10:46:00","modified_gmt":"2021-04-06T17:46:00","slug":"seroprevalence-of-sars-cov-2-and-infection-fatality-ratio-orleans-and-jefferson-parishes-louisiana-usa-may-2020","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/08\/03\/seroprevalence-of-sars-cov-2-and-infection-fatality-ratio-orleans-and-jefferson-parishes-louisiana-usa-may-2020\/","title":{"rendered":"Seroprevalence of SARS-CoV-2 and Infection Fatality Ratio, Orleans and Jefferson Parishes, Louisiana, USA, May 2020"},"content":{"rendered":"<ul>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"34\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"auto\">Among\u00a0<\/span><span data-contrast=\"auto\">2<\/span><span data-contrast=\"auto\">,640\u00a0<\/span><span data-contrast=\"auto\">individuals<\/span><span data-contrast=\"auto\">\u00a0(61% White) in Louisiana, USA, the\u00a0<\/span><span data-contrast=\"auto\">weighted\u00a0<\/span><span data-contrast=\"auto\">SARS-CoV-2 exposure\u00a0<\/span><span data-contrast=\"auto\">rate\u00a0 was<\/span><span data-contrast=\"auto\">\u00a08%. Seroprevalence was highest (10%) in Black participants, followed by multiracial (7%), Asian (6%), and White (5%) participants. The infection fatality ratio was 1.6%, similar for White (1.6%), Black (1.7%), and multiracial (1.4%) persons<\/span><span data-contrast=\"auto\">,<\/span><span data-contrast=\"auto\">\u00a0but was significantly lower for Asian persons (0.6%).\u00a0<\/span><span data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><\/li>\n<\/ul>\n<p><i><span data-contrast=\"none\">Feehan et al. (July 30, 2020). Seroprevalence of SARS-CoV-2 and Infection Fatality Ratio, Orleans and Jefferson Parishes, Louisiana, USA, May 2020. Emerging Infectious Diseases.\u00a0<\/span><\/i><a href=\"https:\/\/doi.org\/10.3201\/eid2611.203029\"><span data-contrast=\"none\">https:\/\/doi.org\/10.3201\/eid2611.203029<\/span><\/a><i><span data-contrast=\"none\">\u00a0<\/span><\/i><span data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559685&quot;:720,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Among\u00a02,640\u00a0individuals\u00a0(61% White) in Louisiana, USA, the\u00a0weighted\u00a0SARS-CoV-2 exposure\u00a0rate\u00a0 was\u00a08%. Seroprevalence was highest (10%) in Black participants, followed by multiracial (7%), Asian (6%), and White (5%) participants. The infection fatality ratio was 1.6%, similar for White (1.6%), Black (1.7%), and multiracial (1.4%) persons,\u00a0but was significantly lower for Asian persons (0.6%).\u00a0\u00a0 Feehan et al. (July 30, 2020). Seroprevalence&#8230;<\/p>\n<div><a class=\"more\" href=\"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/08\/03\/seroprevalence-of-sars-cov-2-and-infection-fatality-ratio-orleans-and-jefferson-parishes-louisiana-usa-may-2020\/\">Read more<\/a><\/div>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[6],"tags":[],"topic":[24],"class_list":["post-8683","post","type-post","status-publish","format-standard","hentry","category-article-summary","topic-geographic-spread"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/8683","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/comments?post=8683"}],"version-history":[{"count":1,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/8683\/revisions"}],"predecessor-version":[{"id":8684,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/8683\/revisions\/8684"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/media?parent=8683"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/categories?post=8683"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/tags?post=8683"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/topic?post=8683"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}